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Background
Malaria morbidity and mortality rates in Sub-Saharan Africa 
are increasing, with the number of World Health Organization 
(WHO)-estimated cases reaching 219 million, with 435 000 
associated deaths, in 20171 comparing to the 216 million scored 
in 2016 which had already increased for about 5 million cases 
over 20152. Malaria prevention relies on vector control using 
insecticides, either by indoor residual spraying (IRS) or in 
long-lasting insecticide-impregnated mosquito bed nets (LLINs). 
The efficacy of these measures depends primarily on the 
susceptibility of the malaria vectors to insecticides. An estimated 
663 million cases of malaria have been averted in sub-Saharan 
Africa between 2000 and 2015 as a result of the scale-up of 
malaria control interventions, of which 68%, 22% and 10% were 
attributed to LLINs, artemisinin-based combination therapy 
(ACT) and IRS, respectively. Unfortunately, despite these efforts, 
the number of resistant mosquito populations is increasing 
dramatically, and the efficacy of pyrethroids (the most commonly 
used insecticide class) is decreasing3,4, which translates to an 
increase in malaria cases1,2.
The two major causes of resistance to pyrethroids include 
alterations in the target site (knockdown resistance (kdr)) and 
increases in the rate of insecticide metabolism by enzymes in 
various P450 families5. This kdr occurs due to mutations in the 
para-gated sodium channel gene. In Anopheles gambiae, two 
kdr mutations (1014F6 and 1014S7) have been identified at the 
same codon.
Studies aimed at estimating the frequency of these mutations 
across Africa have shown that the 1014F kdr mutation has 
spread from West Africa8–11 to East Africa12–14, and the 1014S kdr 
mutation has spread from East Africa to Central and West 
Africa15,16. In Côte d’Ivoire, resistance to insecticides used for 
vector control is prevalent17,18, involving multiple mechanisms19. 
So far, only two cases of East African kdr (1014S) have been 
reported, both a few years ago, in Côte d’Ivoire; the first by 
Chouaibou et al.,20 and the second by Fodjo et al.,18, each on 
individual An. gambiae mosquitoes.
Further follow-up studies carried out recently helped us to 
describe the recent and rapid spread of 1014S mutation in 
Côte d’Ivoire. Interestingly, our key findings demonstrated 
that development of the 1014S mutation occurs exclusively in 
mosquitoes that already have the 1014F mutation. An. gambiae 




The mosquitoes used in this study were collected as part of the 
large bionomic study of malaria transmission in the locality of 
Elibou (5°40′57″N; 4°30′30″W) in South Côte d’Ivoire. Sam-
pling was done in the larval stage in several breeding sites. Larvae 
were evenly pooled together and reared to the adult stage at the 
Centre Suisse de Recherches Scientifiques (CSRS) insectarium 
under standard conditions (temperature of 25–27°C and 70–90% 
relative humidity).
Genotyping of mosquitoes
Genomic DNA was extracted from 70 adult mosquitoes using the 
MegaZorb® DNA Mini-Prep Kit according to the manufacturer 
instructions (Promega Corporation, USA). The identification of 
An. gambiae complex members was made by short interspersed 
element (SINE)-PCR according to the methods described by 
Santolamazza et al.21. The East- and West-African knockdown 
resistance genes were characterized using a triplex assay, 
optimized by Mavridis et al.22 from Bass et al.23 for simulta-
neously detecting the wildtype L1014 and the kdr mutations 
1014F and 1014S in the same reaction. The reaction was 
performed on a Bio-Rad CFX96 Real-Time System using 
DNA extractions of individual mosquitoes in 10-µl reaction 
volumes. Each probe was labelled with a different ﬂuorescent 
dye: HEX for wildtype L1014 (CTTACGACTAAATTTC), 
FAM for 1014F (ACGACAAAATTTC), and Atto for 1014S 
(ACGACTGAATTTC). The cycling conditions used were 50°C 
for 15 min, 95°C for 3 min, and 40 cycles of 95°C for 3 s and 
60°C for 30 s, allowing a PCR run of approximately 70 min. 
Genotypes appeared during amplification as three-color curves.
At the end of this initial molecular analysis, nine mosqui-
toes presented the 1014S mutation. Surprisingly, these same 
mosquitoes also presented the 1014F mutation. To confirm 
genotyping results, the DNA extractions of the same mosquitoes 
were further used in TaqMan assays23 to characterize 1014F and 
1014S mutations. In each of the East-kdr and West-kdr assay, 
two probes labelled with ﬂuorochromes FAM (ID for Lifetech: 
AHGI2PM) and HEX (ID for Lifetech: AHAA5AD) were 
used to detect the mutant alleles and the wild type susceptible 
allele, respectively. The reaction was performed on the Bio-Rad 
CFX96 Real-Time qPCR thermal cycler in 10-µl reactions 
volumes, including master mix, primer/probe, and water. The 
thermal cycle parameters were 10 min at 95°C, then, 40 cycles 
of 10 s at 95°C and 45 s at 60°C. Genotypes were determined 
after real-time amplification from dual-color scatter plots using 
Bio-Rad CFX Manager 3.1 software.
Results
The results obtained with the TaqMan assays and the triplex 
PCR assays were in agreement. Nine out of 70 An. gambiae 
mosquitoes (12.85%) were found to harbor concurrently both the 
1014S kdr mutation and the 1014F kdr mutation (Figure 1 and 
Figure 2). All mosquitoes used in analyses were identified as 
An. gambiae coluzzi. None of the mosquitoes were found to 
have only the 1014S kdr mutation. Raw data are provided on 
OSF24.
Discussion and conclusion
In the current study, 9 out of 70 the species of Anopheles 
coluzzi collected in one locality of Elibou in Côte d’Ivoire 
appeared to have the double East- and West-African kdr 
mutations, whereas just 1 year ago, only 1 mosquito out of 
150 sampled across country had the same genotype. These results 
could be found too preliminary as only one location has been sam-
pled and the change is only observed between two time points. 
Nevertheless, this should be taken seriously since as the pheno-
typic consequences and thus importance of the combination of the 
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Figure 1. East African kdr genotype of wild Elibou Anopheles coluzzi population. The ‘A’, ‘C’, ‘D’ and ‘E’ on the figure are the positive 
controls respectively for the East-kdr homozygous mutant allele, heterozygous mutant/susceptible allele, homozygous susceptible allele and 
blank. Nine mosquitoes (‘B’) displayed the heterozygous
Figure 2. West African kdr genotype of wild Elibou Anopheles coluzzi population. The ‘A’, ‘C’, ‘D’ and ‘E’ on the figure are the positive 
controls respectively for the East-kdr homozygous mutant allele, heterozygous mutant/susceptible allele, homozygous susceptible allele 
and blank. The same nine mosquitoes of Figure 1 displayed the heterozygous (‘B’) genotype. We have not quantified the DNA in extracted 
samples. A low quantity of DNA in the West-kdr homozygous positive control might explain the low signal observed for A.
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mutations in the populations is unknown. We have not provided 
data for the kdr 1014F as this is part of another study. Overall, 
the present study confirms the general trend of intensifica-
tion and propagation of resistance phenomena. The risks and 
consequences for vector control and malaria burden are widely 
documented. WHO25 reported in 2012 that coverage with LLINs 
and IRS in the WHO African Region was estimated to avert 
approximately 220,000 deaths among children under 5 years 
annually. If pyrethroids were to lose most of their efficacy, more 
than 55% of the benefits of vector control would be lost, leading 
to approximately 120 000 deaths that could not be averted. To 
remedy to this, it was found necessary by some companies to 
reformulate some active ingredients previously used exclusively 
in agriculture. This is the case for the neonicotinoids, refor-
mulated by Bayer under the name of Fludora, composed of 
clothianidin and deltamethrin, or by Sumitomo under the name of 
Sumishield, composed of clothianidin. Neonicotinoids exhibit 
a mode of action that is completely different to the one appear-
ing when public health insecticides are used. Neonicotinoids act 
by selectively targeting the invertebrate nicotinic acetylcho-
line receptor (nAChR) and disrupting excitatory cholinergic 
neurotransmission leading to paralysis and death26. Given the 
massive use of neonicotinoids in agriculture18,27, their medium-
to-long-term efficacy on vector populations remains question-
able. An upcoming study have shown that wild populations of 
An. gambiae from agricultural areas of Cote d’Ivoire are already 
resistant to neonicotinoids (Chouaibou et al., Submitted). This 
dilemma reinforces the idea that the reformulation of agricul-
tural insecticides for public health application is not necessarily 
the right solution for vector control, although it may appear as a 
transitional solution. Other solutions include the development 
of new insecticidal molecules dedicated exclusively to vector 
control in the public health sector, as described in the goal of the 
Innovative Vectors Control Consortium for the next 3 to 5 years. 
Other non-chemical methods of vector control should also be 
considered for the future. Given the huge emphasis on chemical- 
based control tools, people may think that chemical-based 
control strategies are the only way to overcome malaria vectors, 
while we are confident that the best approach is the integrated 
vector management strategy that includes all effective and 
available methods. The current study highlights the rapid spread 
of insecticide resistance in malaria vectors, which can lead to 
insecticide-based vector control failure and huge fatalities on 
malaria burden. Thus, collective awareness is essential. Vector 
control interventions must be rethought and reviewed overall; 
reﬂections must be made at all stages, and chemical control must 
not be seen as the ultimate solution.
Data availability
Output data from the genotyping of mosquitoes is available on 
OSF. DOI: https://doi.org/10.17605/OSF.IO/9BDT724.
Data are available under the terms of the Creative Commons 
Zero “No rights reserved” data waiver (CC0 1.0 Public domain 
dedication).
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